3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
10
Phase 1/2
4
Phase 1
4
Phase NA
3
Phase 3
1
Phase 2/3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
16
Tumor-Agnostic
7
Genitourinary
5
Thoracic
4
Head & Neck
4
Dermatologic
4
Breast
4
Sarcoma
2
Endocrine
2
CNS
2
Plasma cell
1
NET
1
Conditions
Neuroendocrine Tumors
7
Somatostatinoma
2
Gastroenteropancreatic Neuroendocrine Tumors
2
Adenoma, Islet Cell
2
Vipoma
1
Pheochromocytoma
1
Paraganglioma
1
Neoplasms
1
Neoplasm Metastasis
1
Lung Neoplasms
1
Insulinoma
1
Glucagonoma
1
Gastrinoma
1
Carcinoma, Islet Cell
1
Carcinoid Tumor
1
Interventions
Everolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Neoplasm Metastasis
×
NET
×
Clear all
NCT06943755
2026-04-17
STELLAR-311
Exelixis
Phase 2/3
Recruiting
440 enrolled